I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Felip, Enriqueta
580
results:
Search for persons
X
Format
Online (580)
Mediatypes
Articles (Online) (208)
OpenAccess-fulltext (372)
Languages
english (522)
more...
spanish (7)
russian (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Trastuzumab deruxtecan in patients with metastatic non-smal..:
Smit, Egbert F
;
Felip, Enriqueta
;
Uprety, Dipesh
...
The Lancet Oncology. 25 (2024) 4 - p. 439-454 , 2024
Link:
https://doi.org/10.1016/..
?
2
Publisher Correction: Anti-TIGIT antibody improves PD-L1 bl..:
Guan, Xiangnan
;
Hu, Ruozhen
;
Choi, Yoonha
...
Nature. 627 (2024) 8005 - p. E11-E11 , 2024
Link:
https://doi.org/10.1038/..
?
3
An algorithm based on immunotherapy discontinuation and liv..:
Riveiro‐Barciela, Mar
;
Barreira‐Díaz, Ana
;
Salcedo, María‐Teresa
...
Alimentary Pharmacology & Therapeutics. 59 (2024) 7 - p. 865-876 , 2024
Link:
https://doi.org/10.1111/..
?
4
RET Fusion Testing in Patients With NSCLC: The RETING Study:
Conde, Esther
;
Hernandez, Susana
;
Rodriguez Carrillo, Jose Luis
...
JTO Clinical and Research Reports. 5 (2024) 4 - p. 100653 , 2024
Link:
https://doi.org/10.1016/..
?
5
Anti-TIGIT antibody improves PD-L1 blockade through myeloid..:
Guan, Xiangnan
;
Hu, Ruozhen
;
Choi, Yoonha
...
Nature. 627 (2024) 8004 - p. 646-655 , 2024
Link:
https://doi.org/10.1038/..
?
6
The impact of decision tools during oncological consultatio..:
Sebri, Valeria
;
Marzorati, Chiara
;
Dorangricchia, Patrizia
...
Cancer Medicine. 13 (2024) 9 - p. , 2024
Link:
https://doi.org/10.1002/..
?
7
147 Evolution of phase 1 clinical trials for head and neck ..:
Rojas, Katerin
;
Hernando, Alberto
;
Assaf, Juan
...
Radiotherapy and Oncology. 192 (2024) - p. S171-S172 , 2024
Link:
https://doi.org/10.1016/..
?
8
Four-year clinical update and treatment switching-adjusted ..:
Carbone, David P.
;
Ciuleanu, Tudor-Eliade
;
Schenker, Michael
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 2 - p. e008189 , 2024
Link:
https://doi.org/10.1136/..
?
9
Publisher Correction: Anti-TIGIT antibody improves PD-L1 bl..:
Guan, Xiangnan
;
Hu, Ruozhen
;
Choi, Yoonha
...
Nature. 630 (2024) 8016 - p. E9-E9 , 2024
Link:
https://doi.org/10.1038/..
?
10
A pragmatic guide for management of adverse events associat..:
Liu, Geoffrey
;
Mazieres, Julien
;
Stratmann, Jan
...
Lung Cancer. 191 (2024) - p. 107535 , 2024
Link:
https://doi.org/10.1016/..
?
11
Neoadjuvant and Adjuvant Treatment for Early-Stage Resectab..:
Spicer, Jonathan D.
;
Cascone, Tina
;
Wynes, Murry W.
...
Journal of Thoracic Oncology. , 2024
Link:
https://doi.org/10.1016/..
?
12
A plain language summary of the PHAROS study: the combinati..:
Riely, Gregory J
;
Smit, Egbert F
;
Ahn, Myung-Ju
...
Future Oncology. 20 (2024) 16 - p. 1047-1055 , 2024
Link:
https://doi.org/10.2217/..
?
13
Clinical Management of Patients with Non-Small Cell Lung Ca..:
Khasraw, Mustafa
;
Yalamanchili, Priyanka
;
Santhanagopal, Anu
...
Advances in Therapy. 41 (2024) 5 - p. 1815-1842 , 2024
Link:
https://doi.org/10.1007/..
?
14
Blood tumor mutational burden and response to pembrolizumab..:
Bar, Jair
;
Esteban, Emilio
;
Rodríguez-Abreu, Delvys
...
Lung Cancer. 190 (2024) - p. 107506 , 2024
Link:
https://doi.org/10.1016/..
?
15
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Pat..:
Neal, Joel W.
;
Santoro, Armando
;
Gonzalez-Cao, Maria
...
JTO Clinical and Research Reports. , 2024
Link:
https://doi.org/10.1016/..
1-15